De Novo
DEN140040: Nautilus BrainPulse 1000
FDA De Novo · jan medical, inc. · decided Aug 1, 2016
Key facts
| De Novo number | DEN140040 |
|---|---|
| Device name | Nautilus BrainPulse 1000 |
| Applicant | jan medical, inc. |
| Product code | POP |
| Date received | Dec 23, 2014 |
| Decision date | Aug 1, 2016 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Neurology |
| FEI number | 3007289746 |
At a glance
- 1–9 Later 510(k)s citing this De Novo
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: